IMAGION BIOSYSTEMS LTD (IBXXF:OTCMKTS)
$0 None (None%)
Analysed IMAGION BIOSYSTEMS LTD (IBXXF:OTCMKTS) News Sources
Presenting on Emerging Growth Conference 87 Day 2 on October 23; Register to live stream
22-10-2025
yahoo.com
Medical-imaging company Imagion Biosystems Lodges IND with FDA for Phase 2 Trial of MagSense® HER2 targeted imaging agent
03-02-2026
yahoo.com
Presenting on Emerging Growth Conference 90 Day 1 on February 25; Register to live stream
24-02-2026
yahoo.com
Imagion Biosystems’ IND Application for MagSense® Phase 2 Clinical Trial Clears FDA Review
02-06-2026
yahoo.com
Presenting on Emerging Growth Conference 93 Day 1 on June 10; Register to live stream
09-06-2026
yahoo.com
What is the current price of IMAGION BIOSYSTEMS LTD (IBXXF:OTCMKTS)?
The current price of IMAGION BIOSYSTEMS LTD (IBXXF:OTCMKTS) is $0.
IMAGION BIOSYSTEMS LTD (IBXXF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of IMAGION BIOSYSTEMS LTD (IBXXF:OTCMKTS) since the previous trading day is $None.
IMAGION BIOSYSTEMS LTD (IBXXF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of IMAGION BIOSYSTEMS LTD (IBXXF:OTCMKTS) since the previous trading day is None%.
What is the most recent average sentiment score for IMAGION BIOSYSTEMS LTD (IBXXF:OTCMKTS)?
The most recent average sentiment score for IMAGION BIOSYSTEMS LTD (IBXXF:OTCMKTS) is 68 out of 100.
What is the most recent average sentiment for IMAGION BIOSYSTEMS LTD (IBXXF:OTCMKTS)?
The most recent sentiment for IMAGION BIOSYSTEMS LTD (IBXXF:OTCMKTS) is .
SEC-8K** Filing Available For IMAGION BIOSYSTEMS LTD (IBXXF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.